2023 trends in competition for pharma companies: podcasts

Following the release of our report on the future of healthcare and life sciences, we have explored competition law trends in the pharmaceutical industry.

2022 was rich in terms of competition enforcement in the HLS sector in Europe and in the UK and 2023 promises to be as active.

After pay-for-delay which seems now settled case law, what will likely be the next abusive practices in the spotlight?

What are the key aspects companies should be aware of when negotiating prices with Health Authorities?

What type of disparagement practices are under the scrutiny of the EU Commission?

Moving production and R&D (back) to the EU: what is the role of state aid rules?

Listen to our podcasts to find out more.

View relevant slides here.